Watchlist Price Alert

Impact BioMedical Inc. (IBO)

AMEX: IBO · Real-Time Price · USD

0.46

-0.04 (-7.63%)

At close: Jun 06, 2025, 3:58 PM

0.47

1.57%

After-hours: Jun 06, 2025, 05:57 PM EDT

Impact BioMedical Cash Flow Statement

Financials in CAD. Fiscal year is undefined.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017
Period Ending	Apr 30, 2023	Jan 31, 2023	Oct 31, 2022	Jul 31, 2022	Apr 30, 2022	Jan 31, 2022	Oct 31, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017
Net Income	-486.6K	-792.86K	-841.96K	-6.55M	-1.17M	-1.04M	-1.73M	-23.16K	-83.42K	-83.08K	-69.58K	-54.56K	-35.51K	-22.16K	-30.82K	-29.82K	-18.2K	-27.42K	-18.39K	-34.09K	-35.77K	-98.44K	-177.61K	-96.47K
Depreciation & Amortization	72.31K	69.43K	66.33K	79.16K	71.57K	68.94K	46.72K	77.00	76.00	76.00	77.00	76.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	25.7K	-2.6K	97.58K	121.95K	40.08K	-47.11K	788.62K	n/a	n/a	19.4K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	94K
Other Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.69K	74.52K	-16.61K	-7.25K	22.32K	12.49K	-23.04K	5.91K	6.53K	-13.35K	12.77K	-6.34K	4.45K	8.72K	-42.52K	35.67K	14.25K
Other Non-Cash Items	17.32K	27.32K	n/a	2.63M	-25	-85	160.48K	n/a	n/a	n/a	n/a	n/a	255.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Income Tax	n/a	210K	n/a	2.71M	n/a	n/a	25.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	199.11K	8.11K	227.62K	-702.36K	297K	-98.12K	-4.23K	13.85K	70.23K	-16.14K	-10.44K	21.16K	10.09K	-23.65K	2.58K	7.05K	-13.96K	12.11K	17.71K	10.25K	1.85K	-48.92K	24.03K	12.23K
Operating Cash Flow	-172.15K	-480.6K	-450.43K	-1.71M	-765.03K	-1.12M	-739.6K	-9.23K	-13.12K	-79.74K	-79.95K	-33.32K	-25.17K	-45.8K	-28.25K	-22.77K	-32.16K	-15.31K	-685	-23.84K	-33.91K	-147.36K	-153.58K	9.76K
Capital Expenditures	-42.74K	-210.79K	-143.24K	-11.77K	-83.91K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.53K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	618.01K	n/a	n/a	-2.67M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	42.93K	n/a	n/a	25K	n/a	n/a	n/a	-25K	n/a	n/a	n/a	n/a	225K	n/a	n/a	n/a	-225K	n/a
Investing Cash Flow	-42.74K	-210.79K	-143.24K	606.25K	-83.91K	11.86K	-2.62M	n/a	n/a	25K	n/a	n/a	n/a	-25K	n/a	-1.53K	n/a	n/a	225K	n/a	n/a	n/a	-225K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.6K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	380K	182.25K	583.22K	-21.89K	-21.85K	-10.99K	1.34M	2.87M	2.03M	30K	40K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	230.81K
Financial Cash Flow	375.93K	179.71K	571.3K	-121.89K	-271.85K	-10.99K	7.41M	2.87M	2.13M	30K	38.4K	79.25K	n/a	n/a	n/a	16.09K	n/a	n/a	n/a	n/a	-400K	n/a	-4.29K	230.81K
Net Cash Flow	161.05K	-511.67K	-22.37K	-1.23M	-1.12M	-1.12M	4.05M	2.86M	2.12M	-24.74K	-41.55K	45.93K	-25.17K	-70.81K	-28.25K	-8.21K	-32.16K	-15.31K	224.31K	-23.84K	-46.16K	-147.36K	-382.88K	240.57K
Free Cash Flow	-214.89K	-691.38K	-593.67K	-1.72M	-848.94K	-1.12M	-739.6K	-9.23K	-13.12K	-79.74K	-79.95K	-33.32K	-25.17K	-45.8K	-28.25K	-24.3K	-32.16K	-15.31K	-685	-23.84K	-33.91K	-147.36K	-153.58K	9.76K